Clinical trial on prevention as well as reduction of chemotherapy-induced neuropathy with acupuncture treatment on the breast cancer patients

INTERVENTION: Control Group:Watch the video;Treatment Group:acupuncture; CONDITION: Chemotherapy‐induced peripheral neuropathy PRIMARY OUTCOME: EORTC QLQ‐CIPN20 scale mean change value; SECONDARY OUTCOME: QLQ‐C30 Scale;KPS;NRS Scale; INCLUSION CRITERIA: (1) Patients with histological diagnosis of stage I‐III breast cancer, excluding distant metastases (2) Patients who plan to receive adjuvant or neoadjuvant chemotherapy (with or without HER‐2 targeted therapy) must be enrolled before the second adjuvant chemotherapy. (3) Over 18 years of age (4) Sign informed consent 6. No serious organic damage to heart, kidney, liver or brain; 7. Signed the informed consent, participated in and randomly assigned to a study group with no history of substance abuse, and actively cooperated with treatment and follow‐up.